Michael Barbella, Managing Editor06.01.22
SHOWA Group is making a concerted effort to reduce medical waste and protect the environment.
The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to the company's single-use, biodegradable nitrile medical gloves. SHOWA Group claims its gloves are the market’s first to be biodegradable.
“Through our Fayette, Alabama glove manufacturing capacity and strategic partnership with Zeon Chemicals that enabled us to secure the lone domestic capability of nitrile butadiene latex, SHOWA stands alone as the only U.S. domestic manufacturer of FDA-cleared, Berry Amendment-compliant Made in America medical PPE gloves,” said Richard Heppell, president and chief operating officer, SHOWA Group. “This means that every aspect of our medical glove production—from manufacturing to raw materials to packaging—is 100 percent sourced in the U.S. and available today for healthcare buyers seeking to end their reliance on Asia suppliers.”
Reliance on overseas PPE suppliers during the pandemic created a perfect storm for healthcare organizations when supply chain breakdowns, crippling delays, price gouging and inferior products put the safety of medical professionals and patients at risk. Research has found the COVID-19 pandemic has created a estimated 8.4 million tons of plastic waste across 193 countries and about 25,900 tons of that waste has leaked into the ocean.
FDA clearance extends across the SHOWA M7005PF single-use nitrile glove product line. M7005PF is a Class I medical device (glove) intended for medical purposes in medical exams or any environment where the examiner and patient require protection from contamination. By using SHOWA’s Eco Best Technology (EBT), M7005PF is fully biodegradable, breaking down by 82 percent in just 386 days when tested in a laboratory.
Additional key product benefits and features include:
“SHOWA launched its biodegradable nitrile gloves a decade ago as an industry first, and since that time we’ve continued to invest in technology that reduces the environmental impact of PPE glove waste—a huge challenge with medical PPE during the pandemic," SHOWA Group RAQA Manager/Technical Manager Brian Moseley noted. "It can take 100 years or more for regular nitrile gloves to decompose in landfill conditions, but with SHOWA’s Eco Best Technology we’ve dramatically reduced decomposition time.”
In February, SHOWA Group announced a major expansion to its Fayette, Ala., manufacturing facility that will increase SHOWA’s annual domestic production capacity to 1.2 billion gloves by the end of 2022, and 2.8 billion gloves once the buildout is complete. The expansion strengthens the country’s domestic supply of medical PPE, and reduces reliance on overseas PPE to ensure the U.S. is better prepared for future pandemics.
SHOWA creates more than 1,800 different kinds of gloves. The company is based in Menlo, Ga.
The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to the company's single-use, biodegradable nitrile medical gloves. SHOWA Group claims its gloves are the market’s first to be biodegradable.
“Through our Fayette, Alabama glove manufacturing capacity and strategic partnership with Zeon Chemicals that enabled us to secure the lone domestic capability of nitrile butadiene latex, SHOWA stands alone as the only U.S. domestic manufacturer of FDA-cleared, Berry Amendment-compliant Made in America medical PPE gloves,” said Richard Heppell, president and chief operating officer, SHOWA Group. “This means that every aspect of our medical glove production—from manufacturing to raw materials to packaging—is 100 percent sourced in the U.S. and available today for healthcare buyers seeking to end their reliance on Asia suppliers.”
Reliance on overseas PPE suppliers during the pandemic created a perfect storm for healthcare organizations when supply chain breakdowns, crippling delays, price gouging and inferior products put the safety of medical professionals and patients at risk. Research has found the COVID-19 pandemic has created a estimated 8.4 million tons of plastic waste across 193 countries and about 25,900 tons of that waste has leaked into the ocean.
FDA clearance extends across the SHOWA M7005PF single-use nitrile glove product line. M7005PF is a Class I medical device (glove) intended for medical purposes in medical exams or any environment where the examiner and patient require protection from contamination. By using SHOWA’s Eco Best Technology (EBT), M7005PF is fully biodegradable, breaking down by 82 percent in just 386 days when tested in a laboratory.
Additional key product benefits and features include:
- Increased dexterity and flexibility
- Powder-free
- Excellent tensile strength
- No natural rubber allergy risks
- Leak and tear resistant
“SHOWA launched its biodegradable nitrile gloves a decade ago as an industry first, and since that time we’ve continued to invest in technology that reduces the environmental impact of PPE glove waste—a huge challenge with medical PPE during the pandemic," SHOWA Group RAQA Manager/Technical Manager Brian Moseley noted. "It can take 100 years or more for regular nitrile gloves to decompose in landfill conditions, but with SHOWA’s Eco Best Technology we’ve dramatically reduced decomposition time.”
In February, SHOWA Group announced a major expansion to its Fayette, Ala., manufacturing facility that will increase SHOWA’s annual domestic production capacity to 1.2 billion gloves by the end of 2022, and 2.8 billion gloves once the buildout is complete. The expansion strengthens the country’s domestic supply of medical PPE, and reduces reliance on overseas PPE to ensure the U.S. is better prepared for future pandemics.
SHOWA creates more than 1,800 different kinds of gloves. The company is based in Menlo, Ga.